Delivery Order SPE2DB20D3101-SPE2DB24FRGC7
Award Date
4/10/24
Potential Completion Date
4/11/24
Potential Value
$12K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $3,208.42 for the supply of the pharmaceutical product MULTAQ 400 MG TABLET 60S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of September 9, 2022.
The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, as a major pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of 4559445022 MULTAQ 400 MG TABLET 60S. The $5,860.23 firm fixed-price delivery order has a completion date of December 23, 2022 and is not designated as a set-aside contract.
Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,430.70 under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The contract is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, with a period of performance through March 2024. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 IDC with the DLA,...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $4,545.58 for the supply of Multaq 400 mg tablets. The award was made by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation.
Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $2,850.60. The contract was awarded by the Defense Logistics Agency (DLA) and is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product.
The contract has an ultimate completion date of February 6, 2023 and uses a Firm Fixed Price pricing type. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This contract award, with a total ceiling value of $79,610.38, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $17,038.26 Firm Fixed Price Delivery Order from the Defense Logistics Agency (DLA) for the pharmaceutical product MULTAQ 400 MG TABLET 60S.
The award is not designated as a set-aside contract. It has an ultimate completion date of June 6, 2023. Amerisourcebergen is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, provides for the delivery of the pharmaceutical product MULTAQ 400 MG TABLET 60S to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $7,277.44, has a completion date of May 1, 2024.
Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,998.62 firm fixed-price delivery order is for the supply of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of December 12, 2024.
AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is a Delivery Order valued at $12,306.66 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, with a period of performance through January 7, 2025.
Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...